AIMS: Sick sinus syndrome is a generalized abnormality of cardiac impulse formation and is responsible for a large proportion of pacemaker implantations. Although the exact aetiology is not known, it is widely accepted that age-dependent degenerative fibrosis of nodal tissue is the most common cause. Despite its importance, an animal model for sick sinus syndrome is lacking. We attempted to generate a mouse model phenocopying the pathohistological changes as well as the characteristic arrhythmic manifestations of this syndrome. METHODS AND RESULTS: We crossed two genetically engineered mouse lines, ROSA-eGFP-DTA and HCN4-KiT-Cre, to achieve an inducible deletion of cells specifically in the cardiac pacemaking and conduction system. This deletion resulted in a degenerative fibrosis of nodal tissue, which accurately reflects the pathohistological findings in human sick sinus syndrome. The extent of the sino-atrial fibrosis could be controlled by varying the dosage of the inducing substance, tamoxifen. A high-dose protocol resulted in the complete ablation of all sino-atrial cells as demonstrated by histochemical analysis and quantitative reverse transcriptase-polymerase chain reaction. The animals developed a variety of arrhythmias, including progressive bradycardia, sinus pauses, supraventricular and ventricular tachycardia and chronotropic incompetence. Remarkably, the complete destruction of the primary pacemaker centre resulted in only a small increase in mortality. CONCLUSION: This study describes the generation and analysis of an inducible mouse model which closely reflects the pathophysiological characteristics of sick sinus syndrome. The model, with the ability to control the extent of nodal cell ablation and fibrosis, offers new insights into sick sinus syndrome and other cardiac conduction diseases.
AIMS: Sick sinus syndrome is a generalized abnormality of cardiac impulse formation and is responsible for a large proportion of pacemaker implantations. Although the exact aetiology is not known, it is widely accepted that age-dependent degenerative fibrosis of nodal tissue is the most common cause. Despite its importance, an animal model for sick sinus syndrome is lacking. We attempted to generate a mouse model phenocopying the pathohistological changes as well as the characteristic arrhythmic manifestations of this syndrome. METHODS AND RESULTS: We crossed two genetically engineered mouse lines, ROSA-eGFP-DTA and HCN4-KiT-Cre, to achieve an inducible deletion of cells specifically in the cardiac pacemaking and conduction system. This deletion resulted in a degenerative fibrosis of nodal tissue, which accurately reflects the pathohistological findings in humansick sinus syndrome. The extent of the sino-atrial fibrosis could be controlled by varying the dosage of the inducing substance, tamoxifen. A high-dose protocol resulted in the complete ablation of all sino-atrial cells as demonstrated by histochemical analysis and quantitative reverse transcriptase-polymerase chain reaction. The animals developed a variety of arrhythmias, including progressive bradycardia, sinus pauses, supraventricular and ventricular tachycardia and chronotropic incompetence. Remarkably, the complete destruction of the primary pacemaker centre resulted in only a small increase in mortality. CONCLUSION: This study describes the generation and analysis of an inducible mouse model which closely reflects the pathophysiological characteristics of sick sinus syndrome. The model, with the ability to control the extent of nodal cell ablation and fibrosis, offers new insights into sick sinus syndrome and other cardiac conduction diseases.
Authors: Martin Müller; Marianne Stockmann; Daniela Malan; Anne Wolheim; Michael Tischendorf; Leonhard Linta; Sarah-Fee Katz; Qiong Lin; Stephan Latz; Cornelia Brunner; Anna M Wobus; Martin Zenke; Maria Wartenberg; Tobias M Boeckers; Götz von Wichert; Bernd K Fleischmann; Stefan Liebau; Alexander Kleger Journal: Stem Cell Rev Rep Date: 2012-09 Impact factor: 5.739
Authors: Motahareh Moghtadaei; Hailey J Jansen; Martin Mackasey; Sara A Rafferty; Oleg Bogachev; John L Sapp; Susan E Howlett; Robert A Rose Journal: J Physiol Date: 2016-10-17 Impact factor: 5.182
Authors: Hong-Chang Luo; Veronica L Dimaano; Jackelyn M Kembro; Alex Hilser; David Hurtado-de-Mendoza; Iraklis Pozios; Miguel S Tomas; Hulya Yalcin; Ketty Dolores-Cerna; Wilfredo Mormontoy; Miguel A Aon; Duke Cameron; David A Bluemke; Kerry J Stewart; Stuart D Russell; Jorge G Cordova; Theodore P Abraham; M Roselle Abraham Journal: Am J Cardiol Date: 2015-02-04 Impact factor: 2.778
Authors: Thomas A Csepe; Jichao Zhao; Brian J Hansen; Ning Li; Lidiya V Sul; Praise Lim; Yufeng Wang; Orlando P Simonetti; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Vadim V Fedorov Journal: Prog Biophys Mol Biol Date: 2015-12-30 Impact factor: 3.667
Authors: Valeria Mezzano; Yan Liang; Adam T Wright; Robert C Lyon; Emily Pfeiffer; Michael Y Song; Yusu Gu; Nancy D Dalton; Melvin Scheinman; Kirk L Peterson; Sylvia M Evans; Steven Fowler; Marina Cerrone; Andrew D McCulloch; Farah Sheikh Journal: Cardiovasc Res Date: 2016-04-20 Impact factor: 10.787
Authors: Rajan Sah; Pietro Mesirca; Marjolein Van den Boogert; Jonathan Rosen; John Mably; Matteo E Mangoni; David E Clapham Journal: Proc Natl Acad Sci U S A Date: 2013-07-22 Impact factor: 11.205